110 related articles for article (PubMed ID: 20852301)
1. De-identification procedure and sample quality of the post-clinical test samples at the bio-repository of the National Cancer Center Hospital (NCCH) in Tokyo.
Furuta K; Yokozawa K; Takada T; Fujiwara Y
Jpn J Clin Oncol; 2011 Feb; 41(2):295-8. PubMed ID: 20852301
[TBL] [Abstract][Full Text] [Related]
2. Bio-repository of post-clinical test samples at the national cancer center hospital (NCCH) in Tokyo.
Furuta K; Yokozawa K; Takada T; Kato H
Jpn J Clin Oncol; 2009 Aug; 39(8):534-9. PubMed ID: 19491083
[TBL] [Abstract][Full Text] [Related]
3. [Re-utilization of clinical laboratory patient-derived samples].
Goto M; Furuta K
Rinsho Byori; 2006 Sep; 54(9):918-23. PubMed ID: 17063873
[TBL] [Abstract][Full Text] [Related]
4. [Improvement of routine works and quality control in mycobacterial laboratory].
Suzuki K; Higuchi T
Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
[TBL] [Abstract][Full Text] [Related]
5. Nordic biological specimen bank cohorts as basis for studies of cancer causes and control: quality control tools for study cohorts with more than two million sample donors and 130,000 prospective cancers.
Pukkala E
Methods Mol Biol; 2011; 675():61-112. PubMed ID: 20949384
[TBL] [Abstract][Full Text] [Related]
6. [What are the requirements for establishing a biological specimen bank?].
Tjønneland AM; Olsen A
Ugeskr Laeger; 2003 Apr; 165(16):1686-8. PubMed ID: 12756832
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
8. [2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].
Denoux Y; Blanc-Vincent MP; Simony-Lafontaine J; Verriele-Beurrier V; Briffod M; Voigt JJ; ; ; ; ; ;
Ann Pathol; 2003 Jun; 23(3):266-78. PubMed ID: 12909833
[TBL] [Abstract][Full Text] [Related]
9. [Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].
Denoux Y; Blanc-Vincent MP; Simony-Lafontaine Jl; Verriele-Beurrier V; Briffod M; Voigt JJ
Bull Cancer; 2002 Apr; 89(4):401-9. PubMed ID: 12016040
[TBL] [Abstract][Full Text] [Related]
10. Organization of a tumor bank: the experience of the National Cancer Institute of Mexico.
Ruíz-Godoy L; Meneses-García A; Suárez-Roa L; Enriquez V; Lechuga-Rojas R; Reyes-Lira E
Pathobiology; 2010; 77(3):147-54. PubMed ID: 20516730
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
12. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
[TBL] [Abstract][Full Text] [Related]
13. [Constitution of a bank of biological material. Practical aspects].
Henny J
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):127-36. PubMed ID: 12684569
[TBL] [Abstract][Full Text] [Related]
14. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
[TBL] [Abstract][Full Text] [Related]
15. Biological sample collection, processing, storage and information management.
Vaught JB; Henderson MK
IARC Sci Publ; 2011; (163):23-42. PubMed ID: 22997855
[TBL] [Abstract][Full Text] [Related]
16. [Mycobacterial tests].
Takashima T; Higuchi T
Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
[TBL] [Abstract][Full Text] [Related]
17. Best practices for establishing a biobank.
Hallmans G; Vaught JB
Methods Mol Biol; 2011; 675():241-60. PubMed ID: 20949394
[TBL] [Abstract][Full Text] [Related]
18. Quality control of human tissues--experience from the Indiana University Cancer Center-Lilly Research Labs human tissue bank.
Sandusky GE; Teheny KH; Esterman M; Hanson J; Williams SD
Cell Tissue Bank; 2007; 8(4):287-95. PubMed ID: 17387635
[TBL] [Abstract][Full Text] [Related]
19. [Biological specimen banks: epidemiological tools and scientific enterprises].
Muti P
Epidemiol Prev; 2003; 27(2):121-5. PubMed ID: 12848025
[TBL] [Abstract][Full Text] [Related]
20. The NCI Biospecimen Research Network.
Moore HM
Biotech Histochem; 2012 Jan; 87(1):18-23. PubMed ID: 21745162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
